Cognition Therapeutics, Inc.
CGTX
$1.80
$0.1911.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.79% | 20.59% | -8.14% | 21.08% | -41.13% |
| Total Depreciation and Amortization | 0.00% | 35.56% | -36.62% | 1.43% | 4.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.94% | 5.97% | 9.74% | -40.40% | -21.88% |
| Change in Net Operating Assets | -403.96% | 121.15% | -77.12% | -154.01% | 1,347.06% |
| Cash from Operations | -0.50% | 43.07% | -17.84% | -22.35% | -14.24% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 65.83% | -1.69% | 39.49% | -5.41% | -2.21% |
| Issuance of Common Stock | 3,776.17% | -39.93% | -88.69% | -- | -- |
| Repurchase of Common Stock | -620.00% | 89.13% | -- | 100.00% | -3,604.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -200.00% | 200.00% |
| Cash from Financing | 4,410.24% | -41.98% | -88.61% | 3,359.27% | 338.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 680.29% | 43.24% | -386.22% | 145.97% | -6.26% |